Savara inc. (SVRA)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Sep'12Jun'12
Net sales

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Licensing revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Grant revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Grant and award revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

-

0

-

0

0

0

Cost of goods sold

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Gross margin

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Operating expenses:
Research and development

13,200

8,723

9,575

10,464

10,019

9,857

9,509

9,268

8,539

6,434

4,966

4,164

2,948

-3,125

2,142

1,290

7,875

-16,785

7,330

7,734

6,042

4,932

5,402

4,820

4,281

3,519

3,102

2,836

3,442

1,657

2,107

General and administrative

2,982

3,296

2,811

4,211

2,763

3,251

3,148

2,486

1,769

2,771

1,486

5,088

1,736

-

1,002

608

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Impairment of acquired IPR&D

-

-

-

-

-

0

0

0

21,692

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Write-off of in-process research and development

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Impairment of goodwill

-

-

-

7,420

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Depreciation

-

-

-

-

-

-

-

-

-

91

91

91

90

-

86

85

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Selling, general and administrative

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,835

-

2,460

2,410

3,578

2,397

2,455

2,370

2,266

2,146

2,158

2,099

2,112

1,816

1,871

Transaction-related expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

2

-11

280

44

0

7

27

-

-

Transaction-related expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

266

-205

Depreciation and amortization

58

-

56

59

138

-

127

153

107

-

-

-

-

-

-

-

32

-

38

37

30

25

25

23

12

11

10

8

9

10

36

Equity in loss of investee

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Total operating expenses

16,240

31,509

12,442

22,154

12,920

13,247

12,784

11,907

32,107

9,296

6,543

9,343

4,774

-4,607

3,230

1,983

10,742

-23,682

9,828

10,181

9,650

7,354

7,884

7,202

6,839

5,722

5,270

4,953

5,592

3,218

4,221

Loss from operations

-16,240

-31,509

-12,442

-22,154

-12,920

-13,247

-12,784

-11,907

-32,107

-9,296

-6,543

-9,343

-4,774

5,007

-3,230

-1,983

-10,742

23,736

-9,828

-10,181

-9,650

-7,354

-7,884

-7,202

-6,839

-5,722

-5,270

-4,953

-5,592

-3,218

-4,221

Other income, net:
Interest expense, net

-160

-86

5

31

-20

117

111

-113

-104

-

-277

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Reduction of fair value of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

Reduction of fair value of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

39

-

32

32

30

19

18

17

15

17

17

10

14

18

19

Interest expense, net

-

-

-

-

-

-

-

-

-

-

-

516

245

-264

190

7

519

2,483

101

1

0

-

-

-

-

-

-

-

0

0

0

Foreign currency exchange gain (loss)

156

-245

116

110

-59

-16

-7

155

-61

7

-71

-122

-32

-

92

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Tax credit income

821

80

54

115

964

143

110

277

924

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Foreign currency exchange loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

84

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on extinguishment of debt

-

-

-

-

-

-

-

-

-

-

-

-1,816

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of financial instruments

2

41

-136

-41

-77

-12

10

-6

-56

100

-43

-177

-160

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of financial instruments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

101

23

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total other income

819

-210

39

215

808

232

224

313

703

-16

-391

-2,631

-437

-282

3

-68

15

-3,064

-15

-1

4

22

0

33

453

0

-0

1

-2

1

-8

Loss before income taxes

-15,421

-31,719

-12,403

-21,939

-12,112

-13,015

-12,560

-11,594

-31,404

-9,312

-6,934

-11,974

-5,211

-

-3,227

-2,051

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income tax benefit

-

-

-

-

-

-2,502

0

0

-4,555

-2,810

-117

-470

-237

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss before cumulative effect of change in accounting principle

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-5,580

-3,199

-4,211

Cumulative effect of change in accounting principle

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Net loss

-15,421

-31,719

-12,403

-21,939

-12,112

-10,513

-12,560

-11,594

-26,849

-6,502

-6,817

-11,504

-4,974

5,562

-3,227

-2,051

-11,207

20,680

-9,912

-10,151

-9,616

-7,313

-7,866

-7,152

-6,371

-5,704

-5,253

-4,941

-5,580

-3,199

-4,211

Accretion of redeemable convertible preferred stock

-

-

-

-

-

-

-

-

-

0

0

554

24

-

44

2

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deemed dividend on beneficial conversion feature

-

-

-

-

-

-

-

-

-

-

-

404

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Preferred stock dividends

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Deemed dividends on preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Net loss attributable to common stockholders

-

-

-

-

-

-

-

-

-

-6,502

-6,817

-12,462

-4,998

-

-3,271

-2,053

-

-

-

-

-

-

-

-

-

-

-

-

-5,580

-3,199

-4,211

Net loss per share:
Basic and diluted

-0.27

-0.74

-0.30

-0.57

-0.34

-0.26

-0.36

-0.37

-0.86

1.07

-0.28

-0.90

-1.65

1.96

-1.21

-1.97

-4.40

-9.30

-0.06

-0.06

-0.06

-0.05

-0.06

-0.06

-0.06

-0.02

-0.05

-0.09

-0.12

-0.07

-0.09

Weighted average common shares outstanding:
Basic and diluted

57,364

43,926

41,727

38,440

36,016

35,967

34,483

31,433

31,318

29,037

24,209

13,807

3,029

1,546

2,707

1,043

2,544

-481,325

163,614

162,128

159,458

145,708

123,287

115,587

105,053

103,617

102,710

53,749

46,265

47,715

47,715

Other comprehensive loss:
Loss on foreign currency translation

-128

274

-436

91

-225

-153

-105

-856

341

253

348

851

143

-

39

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-15,421

-31,719

-12,403

-21,939

-12,112

-10,513

-12,560

-11,594

-26,849

-6,502

-6,817

-11,504

-4,974

5,562

-3,227

-2,051

-11,207

20,680

-9,912

-10,151

-9,616

-7,313

-7,866

-7,152

-6,371

-5,704

-5,253

-4,941

-5,580

-3,199

-4,211

Other comprehensive (loss)/income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

22

-

-1

12

23

0

-7

8

-5

7

-19

1

-8

0

-0

Unrealized gain on short-term investments

17

-55

-12

120

26

-11

13

37

-24

-

-5

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss applicable to common stock

-

-

-

-

-

-

-

-

-

-6,502

-6,817

-12,462

-4,998

-

-3,271

-2,053

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total comprehensive loss

-15,532

-31,500

-12,851

-21,728

-12,311

-10,677

-12,652

-12,413

-26,532

-6,290

-6,474

-10,653

-4,831

4,910

-3,188

-2,051

-11,185

20,646

-9,913

-10,139

-9,593

-7,313

-7,873

-7,144

-6,376

-5,696

-5,273

-4,939

-5,589

-3,198

-4,211